Mallorie H Fiero

10PUBLICATIONS
70CO-AUTHORS
Food safety, traceability, certification and authenticityCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology not elsewhere classifiedPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 30, 2026
Is Progression-Free Survival 2 Ready for Prime Time in US Food and Drug Administration Regulatory Decision Making?

Mallorie H Fiero, Mirat Shah, Laleh Amiri-Kordestani

|Feb 12, 2026
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer.

Nooshin Mirkheshti, Daniel Edem Kpormegbey, Chana Weinstock

|Aug 18, 2025
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ.

Brian L Heiss, Elaine Chang, Hee-Koung Joeng

|Jul 17, 2025
FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.

William F Maguire, Dow-Chung Chi, Sundeep Agrawal

|Sep 09, 2024
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.

Jaleh Fallah, Brian L Heiss, Hee-Koung Joeng

|Sep 04, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.

Michael H Brave, William F Maguire, Chana Weinstock

Pageof 2

Frequent Collaborators

9 joint publications

Laleh Amiri-Kordestani

8 joint publications

William F Pierce

7 joint publications

Richard Pazdur

6 joint publications

Daniel L Suzman